Q4 2022 InMed Pharmaceuticals Inc Earnings Call Transcript
Good day and thank you for standing by. Welcome to the InMed Pharmaceuticals' fourth-quarter fiscal 2022 financial results and business update conference call. (Operator Instructions)
Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Colin Clancy, Vice President of Investor Relations.
Thank you, Norma, and good day, ladies and gentlemen. My name is Colin Clancy, InMed's Vice President of Investor Relations. Welcome to InMed's fiscal year and 2022 financial results and business update conference call.
Please note our speakers are joining today from remote locations, so we appreciate your patience if we encounter any unexpected technical challenges.
Before we begin, we would like to go over our disclosure statements, followed by a progress report on our pharmaceutical drug development program, led by our President and CEO, Eric Adams, together with an update on our health and wellness commercial activities
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |